Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03813602Phase 2Completed
Phase 2, open-label, single-arm trial, sponsored by Center for Addiction and Mental Health. Primary endpoint: Change in eye gaze at 5 hours. Started Aug 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03813602.